Long acting beta agonists. are they safe?
dc.contributor.author | Wijesiriwardena, B. | |
dc.date.accessioned | 2016-01-14T09:41:57Z | |
dc.date.available | 2016-01-14T09:41:57Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | The Ceylon Medical Journal, 51(04)pp.129-131 | |
dc.identifier.issn | 0009-0875 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/21079 | |
dc.publisher | Sri Lanka Medical Association. Colombo | |
dc.subject | Medical Sciences | |
dc.subject | Asthma | |
dc.subject | Drug therapy | |
dc.subject | Beta agonists | |
dc.subject | Long acting beta agonists | |
dc.subject | LABA | |
dc.subject | Adverse effects | |
dc.subject | Salmeterol | |
dc.subject | Formoterol | |
dc.subject | Disease management | |
dc.subject | Drug effects | |
dc.title | Long acting beta agonists. are they safe? | |
dc.type | Article |